ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 658229 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 658229; 2) Community: the network communities that were significantly associated with the response to NSC 658229; 3) Molecule: the relationships between components within communities and NSC 658229; 4) MDR: the compounds that were significantly associated with the NSC 658229.

NSC Compound Enrichment Correlation
NSC 688816 Null 0.036145517892443 -0.35289534
NSC 112152 2H,4aH-1,4,5-Trioxadicyclopent[a,hi]indene-7-carboxylic acid, 3-ethylidene-3,3a,7a,9b-tetrahydro-2-oxo-, methyl ester, [3aS-(3E,3a.alpha.,4a.beta.,7a.beta.,9aR*,9b.beta.)]- (9CI) 0.0376362543535812 0.13914531
NSC 113951 6-Bromotoyocamycin 0.0376362543535812 0.24119887
NSC 269599 Stannane, chlorohydroxydiphenyl- 0.0376362543535812 0.0519968
NSC 319079 Null 0.0376362543535812 0.22450959
NSC 328166 8B-Hydroxy-9B,10B-epoxyverrucarin A 0.0376362543535812 0.2067897
NSC 357288 LIATRIS LAEVIGATA LACTONE #2 0.0376362543535812 0.20236182
NSC 363812 Tetraplatin 0.0376362543535812 0.24914177
NSC 373980 Null 0.0376362543535812 0.23833948
NSC 5053 2,3,5-Triphenyltetrazolium chloride 0.0376362543535812 0.052150915
Total:145  Current:113    [First] [Prev] [Next] [Last]